Birdwatch Note
2024-10-16 15:15:04 UTC - NOT_MISLEADING
NNN, proposed note is false: Ivermectin, a potential anticancer drug derived from an antiparasitic drug https://www.sciencedirect.com/science/article/pii/S1043661820315152 Ivermectin and Pembrolizumab for the Treatment of Metastatic Triple Negative Breast Cancer https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-02421 Ivermectin, a potential anticancer drug derived from an antiparasitic drug https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
Written by D592B73D04BBA2DA7B8C20EAEBE570181B89BB25ADDF13BBEA032A54C7BCE545
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1846256384825848190
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1846570564179186121
- noteId - 1846570564179186121
- participantId -
- noteAuthorParticipantId - D592B73D04BBA2DA7B8C20EAEBE570181B89BB25ADDF13BBEA032A54C7BCE545 Participant Details
- createdAtMillis - 1729091704780
- tweetId - 1846256384825848190
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- NNN, proposed note is false: Ivermectin, a potential anticancer drug derived from an antiparasitic drug https://www.sciencedirect.com/science/article/pii/S1043661820315152 Ivermectin and Pembrolizumab for the Treatment of Metastatic Triple Negative Breast Cancer https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2022-02421 Ivermectin, a potential anticancer drug derived from an antiparasitic drug https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/
Note Ratings
| rated at | rated by | |
| 2024-10-17 08:09:50 -0500 | Rating Details | |
| 2024-10-16 23:28:17 -0500 | Rating Details | |
| 2024-10-16 18:56:05 -0500 | Rating Details | |
| 2024-10-16 16:31:15 -0500 | Rating Details | |
| 2024-10-16 15:13:48 -0500 | Rating Details | |
| 2024-10-16 13:42:26 -0500 | Rating Details | |
| 2024-10-16 12:47:57 -0500 | Rating Details | |
| 2024-10-16 12:26:07 -0500 | Rating Details | |
| 2024-10-16 11:33:22 -0500 | Rating Details | |
| 2024-10-16 10:45:44 -0500 | Rating Details | |
| 2024-10-17 10:20:18 -0500 | Rating Details | |
| 2024-10-16 21:50:44 -0500 | Rating Details | |
| 2024-10-16 19:02:03 -0500 | Rating Details | |
| 2024-10-16 16:36:40 -0500 | Rating Details | |
| 2024-10-16 13:33:24 -0500 | Rating Details | |
| 2024-10-16 12:39:18 -0500 | Rating Details | |
| 2024-10-16 10:47:52 -0500 | Rating Details | |
| 2024-10-16 10:28:07 -0500 | Rating Details | |
| 2024-10-16 10:27:56 -0500 | Rating Details | |
| 2024-10-16 14:23:26 -0500 | Rating Details | |
| 2024-10-16 13:16:59 -0500 | Rating Details | |
| 2024-10-16 10:17:29 -0500 | Rating Details | |
| 2024-10-17 06:59:44 -0500 | Rating Details | |
| 2024-10-16 23:57:40 -0500 | Rating Details | |
| 2024-10-16 21:50:31 -0500 | Rating Details | |
| 2024-10-16 14:26:07 -0500 | Rating Details | |
| 2024-10-16 13:35:26 -0500 | Rating Details | |
| 2024-10-16 12:43:08 -0500 | Rating Details | |
| 2024-10-16 11:27:44 -0500 | Rating Details | |
| 2024-10-17 05:15:33 -0500 | Rating Details | |
| 2024-10-17 03:24:47 -0500 | Rating Details | |
| 2024-10-16 22:54:54 -0500 | Rating Details | |
| 2024-10-16 15:24:26 -0500 | Rating Details | |
| 2024-10-16 14:27:54 -0500 | Rating Details | |
| 2024-10-16 13:35:58 -0500 | Rating Details | |
| 2024-10-16 13:07:46 -0500 | Rating Details |